Key Points — Oncoclinicas signed a non-binding agreement with insurer Porto Seguro to create a new oncology company, with Porto investing R$500 million ($94 million) for at least 30% of the new entity — The new company would also issue R$500 million ($94 million) in convertible debentures subscribed by Porto, bringing the potential total commitment […] The post Oncoclinicas, Porto Seguro Eye R$1B Oncology JV appeared first on The Rio Times .